Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation (Q80470323)
Jump to navigation
Jump to search
scientific article published on 01 June 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation |
scientific article published on 01 June 2007 |
Statements
Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation (English)
Philip G Thomas
Jacqueline A Lappin
Smita Vaidya
Srinivasan Rajaraman
Kristene K Gugliuzza